The effects of information framing on intentions to vaccinate against human papilloma virus.

B28 null null In June 2006, the Food and Drug Administration (FDA) approved a vaccine to prevent human papilloma virus (HPV), the most common sexually transmitted infection (STI) in the United States and the leading cause of cervical cancer. Because the vaccine was approved for females as young as 9, its success depends largely on parents9 and individuals9 willingness to accept vaccination. It is unknown whether attitudes toward vaccination will...